The case In May, Novo Nordisk moved the Delhi HC against DRL, seeking that the Indian firm and its distributors be restrained from using, manufacturing, selling, distributing, advertising, exporting semaglutide active pharmaceutical ingredient (API) or any product derived from it
Social Media: Follow the latest news and airport updates on its official pages on social networks such as Facebook and Twitter
Blood 94 : 21022111 Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD and Waalkes MP (2001) Overexpression of glutathione S -transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic
PMID: 16194643, DOI: 10.1016/j.amjmed.2005.01.075